
|Articles|December 1, 2002
The American Journal of Managed Care
- December 2002
- Volume 8
- Issue 12
Economic Evaluation of Enoxaparin as Prophylaxis Against Venous Thromboembolism in Seriously Ill Medical Patients: A US Perspective
Author(s)Gregory de Lissovoy, PhD, Prasun Subedi, BS
Advertisement
Articles in this issue
Newsletter
Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.
Advertisement















































